Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02599194
What this trial is testing

18F-FSPG PET/CT for Cancer Patients on Therapy

Who this might be right for
B-Cell NeoplasmEstrogen Receptor NegativeHER2/Neu Negative+13 more
Andrei Iagaru 7
Not applicableLooking for participantsNCT03683680
What this trial is testing

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Who this might be right for
Mesothelioma
Dana-Farber Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT00309946
What this trial is testing

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Looking for participantsNCT05932199
What this trial is testing

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

Who this might be right for
Mesothelioma
Baylor College of Medicine 52
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00054002
What this trial is testing

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Roswell Park Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT04177953
What this trial is testing

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery

Who this might be right for
Pleural Mesothelioma Malignant
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT06155279
What this trial is testing

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

Who this might be right for
Pleural Mesothelioma
Istituto Oncologico Veneto IRCCS 41
Testing effectiveness (Phase 2)Study completedNCT05449366
What this trial is testing

Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma

Who this might be right for
Peritoneal Malignant Mesothelioma
Erasmus Medical Center 7
Large-scale testing (Phase 3)WithdrawnNCT02511600
What this trial is testing

Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication

Who this might be right for
Lung DiseasesMesothelioma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02899195
What this trial is testing

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
PrECOG, LLC. 55
Testing effectiveness (Phase 2)Temporarily pausedNCT01627795
What this trial is testing

Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment

Who this might be right for
Mesothelioma
Oshadi Drug Administration 17
Not applicableUnknownNCT05228795
What this trial is testing

Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

Who this might be right for
Lung Cancer AdenocarcinomaLung Cancer Squamous CellMesothelioma; Lung
Sohag University 60
Testing effectiveness (Phase 2)Study completedNCT00541073
What this trial is testing

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
Centre Oscar Lambret 60
Testing effectiveness (Phase 2)Ended earlyNCT03926143
What this trial is testing

A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies

Who this might be right for
Solid Tumors
Bayer 9
Early research (Phase 1)Ended earlyNCT03436732
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT01869023
What this trial is testing

Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma

Who this might be right for
Advanced Malignant Pleural Mesothelioma
Instituto Nacional de Cancerologia de Mexico 26
Testing effectiveness (Phase 2)Study completedNCT05918107
What this trial is testing

PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM

Who this might be right for
MPM
Biotheus Inc. 31
Not applicableStudy completedNCT02269878
What this trial is testing

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 68
Early research (Phase 1)Study completedNCT01938443
What this trial is testing

A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors

Who this might be right for
CancerNeoplasms
GlaxoSmithKline 34
Next Page